Study guide
4.2 Microbiology, Immunology, and Infection Pathogenesis
Integrated National Board Dental Examination INBDE
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: INBDE Exam Structure & Test Specifications
1.1 INBDE Format, Administration, Scoring & Retesting 1.2 The Domain of Dentistry: Test Specifications, Item Formats, Patient Boxes & Dental Charts
2 Chapter 2: Foundation Knowledge — Anatomic Sciences & Development
2.1 Gross & Head/Neck Anatomy and Histology 2.2 Oral Embryology, Tooth Development & Eruption 2.3 Genetic, Congenital & Developmental Conditions
3 Chapter 3: Foundation Knowledge — Biochemistry, Physiology & Physical Sciences
3.1 Biochemistry and Systemic Physiology 3.2 Physics & Chemistry of Oral Biology: pH, Diffusion & Demineralization
4 Chapter 4: Foundation Knowledge — Pathology, Microbiology & Immunology
4.1 General & Systemic Pathology 4.2 Microbiology, Immunology, and Infection Pathogenesis
5 Chapter 5: Foundation Knowledge — Pharmacology
5.1 Dental Pharmacology, Local Anesthetics, and Analgesics 5.2 Systemic Medications and Drug Interactions in Dentistry
6 Chapter 6: Foundation Knowledge — Dental Anatomy, Occlusion & Materials
6.1 Tooth Morphology, Anatomy, and Occlusion Biomechanics 6.2 Dental Materials Science, Biomaterials, and Impression Systems
7 Chapter 7: Patient Evaluation & Data Gathering
7.1 Chief Complaint, History Taking & Information from Diverse Sources 7.2 Comprehensive Patient History, Examination, and Medical Risk Assessment 7.3 Vital Signs, ASA Physical Status & Medical Risk Stratification 7.4 Normal Findings vs Significant Deviations Requiring Management
8 Chapter 8: Diagnostic Imaging
8.1 Dental Radiology Physics, Safety, and Imaging Interpretation 8.2 Intraoral Radiographic Technique, Errors & Quality Assurance 8.3 Radiographic Interpretation of Caries, Periapical & Bone Lesions 8.4 Panoramic, CBCT & Selection Criteria for Advanced Imaging
9 Chapter 9: Diagnostic Reasoning & Systemic Assessment
9.1 Diagnostic Testing, Laboratory Values, and Medical Complexities 9.2 Predictive Diagnostic Reasoning & Selecting the Right Diagnostic Test 9.3 Oral–Systemic Interrelationships 9.4 Differential Diagnosis of Orofacial Pain
10 Chapter 10: Oral Pathology & Mucosal Disease
10.1 Benign and Malignant Oral Pathology and Biopsy Protocols 10.2 Managing Oral Mucosal and Osseous Diseases
11 Chapter 11: Treatment Planning, Prognosis & Communication
11.1 Interdisciplinary Treatment Planning Sequencing and Prognosis 11.2 Prognosis Determination & Presenting Treatment Alternatives 11.3 Informed Consent, Refusal & Patient Education 11.4 Patient Attributes, Culture, Social Background & Care Across the Lifespan 11.5 Psychological, Social & Behavioral Principles in Patient Communication 11.6 Evaluating the Outcomes of Comprehensive Dental Care
12 Chapter 12: Medical & Dental Emergencies
12.1 Dental and Medical Emergencies in the Dental Office 12.2 Recognizing and Triaging Dental Emergencies
13 Chapter 13: Caries, Operative & Esthetic Dentistry
13.1 Caries Risk Assessment, Prevention, and Operative Dentistry 13.2 Adhesive Dentistry, Composite/Amalgam Restorations, and Esthetics 13.3 Managing the Esthetic Needs of Patients
14 Chapter 14: Endodontics
14.1 Pulpal Biology, Endodontic Diagnosis, and Emergency Treatment 14.2 Endodontic Therapy, Root Canal Instrumentation, Obturation, and Surgery
15 Chapter 15: Periodontics & Implantology
15.1 Periodontal Pathogenesis, Etiology, and Disease Classification 15.2 Non-Surgical Periodontal Therapy and Maintenance Protocols 15.3 Surgical Periodontics, Mucogingival Procedures, and Regenerative Care 15.4 Dental Implants: Planning, Surgical Placement, and Restorative Options
16 Chapter 16: Prosthodontics & Laboratory Communication
16.1 Fixed Prosthodontics: Crown/Bridge Preparation, Design, and Cementation 16.2 Removable Complete Dentures: Impression, Occlusion, and Delivery 16.3 Removable Partial Dentures: Components, Design, and Frameworks 16.4 Communicating Case Design to the Dental Laboratory
17 Chapter 17: Pain Control, Anesthesia & Oral Surgery
17.1 Local Anesthetic Techniques, Complications, and Nitrous Oxide Sedation 17.2 Dentoalveolar Surgery, Tooth Extraction, and Surgical Complications 17.3 Maxillofacial Trauma, Odontogenic Infections, and Complex Surgery
18 Chapter 18: Occlusion, TMD & Orthodontics
18.1 Craniofacial Growth, Development, and Orthodontic Diagnosis/Intervention 18.2 Developmental & Acquired Occlusal Problems 18.3 Temporomandibular Disorders: Diagnosis and Management
19 Chapter 19: Pediatric, Special Care & Vulnerable Patients
19.1 Pediatric Dental Care, Behavior Guidance, and Preventive Services 19.2 Pediatric Restorative Dentistry, Pulpal Therapy, and Dental Trauma 19.3 Special Care Dentistry: Geriatric, Special Needs, and Medically Compromised Patients 19.4 Recognizing, Managing & Reporting Patient Abuse and Neglect 19.5 Recognizing and Managing Substance Use Disorders
20 Chapter 20: Practice Management, Safety Systems & Informatics
20.1 Infection Control Protocols, Sterilization, and OSHA Compliance 20.2 Radiation Safety Guidelines, Dosimetry, and ALARA Principles 20.3 Practice Business Operations, OSHA & Regulatory Compliance 20.4 Catastrophe Preparedness & Practice Continuity Planning 20.5 Managing, Coordinating & Supervising Allied Dental Personnel 20.6 Quality Assurance, Assessment and Improvement 20.7 Dental Informatics, Electronic Records & Emerging Technology 20.8 Scope of Competence, Referral & Professional Self-Assessment
21 Chapter 21: Ethics, Jurisprudence, Evidence & Public Health
21.1 ADA Ethics Code, Jurisprudence, HIPAA, and Professional Conduct 21.2 Evidence-Based Dentistry, Clinical Epidemiology, and Dental Public Health 21.3 Biostatistics, Study Design & Critical Appraisal 21.4 Community Collaboration & Systems of Oral Health Care Delivery 21.5 Emerging Trends and Social/Economic Forces in Oral Health Care 21.6 Prevention, Intervention & Patient Education Strategies
4.2 Microbiology, Immunology, and Infection Pathogenesis
Key Takeaways Explain This Topic AI
Streptococcus mutans initiates caries by synthesizing insoluble glucans from sucrose using Glucosyltransferase (GTF)
Porphyromonas gingivalis (Red Complex) expresses gingipains (cysteine proteases) and endotoxin to destroy periodontal tissues
Gram-negative Lipid A (toxic component of LPS) activates TLR4 on macrophages, triggering septic shock
Oral Hairy Leukoplakia is a non-wipeable white corrugated lesion on lateral tongue borders caused by Epstein-Barr Virus (EBV)
Pemphigus vulgaris involves IgG autoantibodies against Desmoglein 3 causing suprabasal acantholysis; Type IV hypersensitivity is uniquely cell-mediated (T-cells) peaking at 48-72 hours
Last updated: August 2026
- 1.4 Microbiology, Immunology, and Infection Pathogenesis
- Oral Microbiome Composition & Pathogenic Complexes
The oral cavity harbors a complex polymicrobial biofilm. Specific bacterial complexes are etiologically linked to dental caries and periodontal disease.
Cariogenic Bacteria
Streptococcus mutans : The primary initiator of dental caries. Essential virulence factors:
Acidogenicity : Ferments dietary carbohydrates (sucrose) into lactic acid.
Aciduricity : Survives and functions in low pH environments.
Extracellular Polysaccharide Synthesis : Produces the enzyme Glucosyltransferase (GTF) , which cleaves sucrose into glucose and fructose, polymerizing glucose into insoluble sticky glucans (dextrans) that mediate firm adherence to the enamel pellicle.
Lactobacillus species : Secondary invaders that proliferate in acidic environments, driving progression of deep dentinal caries .
Actinomyces viscosus / naeslundii : Filamentous organisms strongly associated with root surface caries .
Periodontopathogenic Bacterial Complexes (Socransky Complexes) ORAL BIOFILM SUCCESSION:
- Early Colonizers (Gram-Positive Streptococci/Actinomyces)
- ↓
- Orange Complex (Fusobacterium nucleatum - Key Bridging Organism)
- ↓
- Red Complex (Porphyromonas gingivalis, Tannerella forsythia, Treponema denticola)
Red Complex : Strongly associated with severe, advanced periodontitis, deep pocketing, and active bone loss:
Porphyromonas gingivalis : Obligate anaerobic Gram-negative rod. Expresses gingipains (cysteine proteinases that degrade collagen and immunoglobulins), fimbriae, and endotoxin LPS.
Tannerella forsythia : Anaerobic Gram-negative rod.
Treponema denticola : Anaerobic Gram-negative spirochete producing dentilisin.
Orange Complex : Species such as Fusobacterium nucleatum act as essential bridging organisms , possessing surface adhesins that co-aggregate early Gram-positive colonizers with late Gram-negative anaerobes.
Aggregatibacter actinomycetemcomitans (Aa) : Gram-negative facultative capnophilic rod that produces Leukotoxin (kills PMNs and monocytes). Etiologic agent of Localized Aggressive Periodontitis (Stage III/IV Grade C periodontitis).
Bacterial Cell Wall Architecture & Endotoxin Action
- Structural Feature Gram-Positive Bacteria Gram-Negative Bacteria
- Peptidoglycan Layer Thick, multi-layered (up to 90% of cell wall) Thin, single-layered (~10% of cell wall)
- Outer Membrane Absent Present (contains LPS and Porin channels)
- Lipopolysaccharide (LPS) Absent Present (outer leaflet of outer membrane)
- Teichoic / Lipoteichoic Acid Present Absent
- Gram Stain Reaction Retains Crystal Violet-Iodine; Stains Purple Counterstained by Safranin; Stains Pink/Red
- Endotoxin (LPS) Structure & Mechanism of Septic Shock
Lipopolysaccharide (LPS) consists of three covalently linked regions:
O-Antigen Polysaccharide : Outer region; variable carbohydrate chains used for serotyping.
Core Polysaccharide : Connects O-antigen to Lipid A.
Lipid A (Toxic Component) : Embedded in outer membrane.
Mechanism of Endotoxicity: Upon cell lysis, Lipid A binds to CD14 / Toll-Like Receptor 4 ( TLR4 ) on macrophages, triggering massive systemic release of pro-inflammatory cytokines ( TNF-alpha, IL-1, IL-6 ). This leads to septic shock , systemic fever, profound hypotension, and Disseminated Intravascular Coagulation (DIC).
- Viral Pathogens: Herpesviruses, Hepatitis & HIV
- Human Herpesviruses (Enveloped Double-Stranded DNA Viruses)
HSV-1 : Causes Primary Herpetic Gingivostomatitis (in children: painful, diffuse oral vesicles and ulcers on both keratinized and non-keratinized mucosa, high fever, cervical lymphadenopathy) and Recurrent Herpes Labialis (cold sores: latent in Trigeminal Ganglion , recurring at vermilion border as clustered vesicles on keratinized mucosa).
Varicella-Zoster Virus (VZV / HHV-3) : Primary infection causes Varicella (chickenpox). Reactivation causes Herpes Zoster (Shingles) , manifesting as painful crops of vesicles strictly limited to a unilateral dermatome along CN V1, V2, or V3.
Epstein-Barr Virus (EBV / HHV-4) : Latent in B lymphocytes. Causes Infectious Mononucleosis, Burkitt Lymphoma, and Oral Hairy Leukoplakia (OHL) (white, corrugated, non-wipeable hyperkeratotic plaque on the lateral borders of the tongue in immunocompromised/HIV patients).
Kaposi Sarcoma-Associated Herpesvirus (HHV-8) : Causes Kaposi Sarcoma , a vascular tumor presenting as red, purple, or bluish macules/nodules on the hard palate or gingiva in AIDS patients.
Hepatitis Viruses & Dental Implications
Hepatitis B Virus (HBV) : Enveloped dsDNA virus transmitted parenterally, sexually, or via blood contact. HBsAg indicates active or chronic infection; Anti-HBs indicates immunity (vaccination or recovery). Healthcare providers are required to receive the HBV vaccine series.
Hepatitis C Virus (HCV) : Enveloped ssRNA virus transmitted via blood. Possesses the highest rate of progression to chronic hepatitis (80%) , cirrhosis, and hepatocellular carcinoma.
Human Immunodeficiency Virus (HIV / AIDS)
Retrovirus carrying Reverse Transcriptase that infects CD4+ T helper cells .
AIDS Diagnosis : CD4+ T cell count < 200 cells/µL or presence of an AIDS-defining opportunistic condition.
Oral Markers of HIV : Pseudomembranous Candidiasis, Oral Hairy Leukoplakia, Kaposi Sarcoma, Linear Gingival Erythema (LGE) , and Necrotizing Ulcerative Periodontitis (NUP) .
Fungal Infections: Candida Albicans Variants & Antifungal Therapy
Candida albicans is a dimorphic commensal fungal organism (yeast form at 37°C, invading tissue via hyphae and pseudohyphae).
Clinical Variants of Oral Candidiasis
Pseudomembranous Candidiasis (Thrush) : Creamy white, curd-like plaques that can be wiped off with gauze, leaving an underlying erythematous, raw, bleeding mucosal surface.
Erythematous Candidiasis : Red, depapillated mucosal macules; common on hard palate under dentures ( Denture Stomatitis ) or following broad-spectrum antibiotic therapy.
Chronic Hyperplastic Candidiasis : White, firm plaque typically at buccal commissures that CANNOT be wiped off .
Angular Cheilitis : Erythema, cracking, and fissuring at the labial commissures; frequently a co-infection of Candida albicans and Staphylococcus aureus .
Pharmacotherapy : Topical Nystatin suspension or Clotrimazole troches for localized oral infection; oral Fluconazole for systemic or refractory cases.
- Host Immune Response & Hypersensitivity Reactions
- Immunoglobulin Classes & Functions
IgG : Most abundant serum antibody (~80%). Only antibody that crosses the placenta . Mediates secondary immune response, opsonization, and complement activation.
IgA : Dimeric structure in secretions (saliva, tears, milk). Contains a secretory component that resists proteolytic enzymatic cleavage. Primary mucosal defense antibody.
IgM : Pentameric structure with 10 antigen-binding sites. First antibody produced during primary immune response . Most efficient activator of the classical complement pathway.
IgE : Binds Fc-epsilon receptors on mast cells and basophils. Mediates Type I hypersensitivity reactions and immunity against parasitic helminths.
Classification of Hypersensitivity Reactions
Memory Aid: "ACID" → A naphylactic (Type I), C ytotoxic (Type II), I mmune Complex (Type III), D elayed (Type IV). Type I --> IgE-Mediated (Anaphylaxis, Urticaria, Penicillin Allergy)
- Type II --> Cytotoxic IgG/IgM (Pemphigus Vulgaris, Mucous Membrane Pemphigoid)
- Type III --> Immune Complex Deposition (Systemic Lupus Erythematosus)
- Type IV --> T-Cell Mediated / Delayed (Contact Dermatitis, Tuberculin Skin Test)
Type I (Anaphylactic / Immediate) : IgE-mediated. Antigen cross-links IgE on mast cells, causing degranulation of histamine, leukotrienes, and prostaglandins. Examples: Anaphylaxis, allergic asthma, penicillin allergy.
Type II (Cytotoxic / Antibody-Mediated) : IgG or IgM antibodies target specific cell-surface or tissue antigens, triggering complement lysis or phagocytosis.
Pemphigus Vulgaris : Autoantibodies against Desmoglein 3 (desmosomes). Causes intraepithelial suprabasal acantholysis and a positive Nikolsky sign .
Mucous Membrane Pemphigoid : Autoantibodies against BP180 / Hemidesmosomes . Causes subepithelial basement membrane split .
Type III (Immune Complex-Mediated) : Circulating antigen-antibody complexes deposit in blood vessel walls, activating complement and recruiting neutrophils. Examples: Systemic Lupus Erythematosus (SLE), Serum Sickness.
Type IV (Delayed / Cell-Mediated) : Mediated by sensitized T-lymphocytes (CD4+ or CD8+) ; NO antibodies involved . Peak reaction occurs 48 to 72 hours post-exposure. Examples: Contact dermatitis (latex, poison ivy, nickel), Mantoux tuberculin skin test.